---
title: "300497.SZ (300497.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300497.SZ/news.md"
symbol: "300497.SZ"
name: "300497.SZ"
parent: "https://longbridge.com/en/quote/300497.SZ.md"
datetime: "2026-05-20T22:16:18.297Z"
locales:
  - [en](https://longbridge.com/en/quote/300497.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300497.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300497.SZ/news.md)
---

# 300497.SZ (300497.SZ) — Related News

### [Fushine: Shareholder Yu Wenjun plans to reduce holdings by 2.45%](https://longbridge.com/en/news/286907650.md)
*2026-05-19T12:00:35.000Z*
> Fushine announced that shareholder Yu Wenjun, holding 13.2164 million shares (accounting for 2.45%), intends to reduce h

### [Fushine: The stock abbreviation has been changed to "Fushine Co., Ltd."](https://longbridge.com/en/news/286418025.md)
*2026-05-14T12:37:26.000Z*
> Fushine announced that the ninth meeting of the fifth board of directors reviewed and approved the proposal to change th

### [Fushine: The controlling shareholder has partially lifted the pledge on shares](https://longbridge.com/en/news/285342106.md)
*2026-05-06T08:57:22.000Z*
> Fushine announced that its controlling shareholder Bao Jianhua has lifted the pledge on part of his shares, involving 10

### [The price of lithium battery electrolyte additives has surged, with net profit attributable to the parent company increasing more than 20 times in the first quarter! A representative from Fushine expressed optimism about demand in the coming years](https://longbridge.com/en/news/284377646.md)
*2026-04-28T06:48:13.000Z*
> Fushine Pharmaceutical (SZ300497) released its 2025 annual report and 2026 first quarter report, showing a 0.61% year-on

### [Fushine: New energy business leads strongly, with net profit increasing over 26 times in the first quarter](https://longbridge.com/en/news/284287953.md)
*2026-04-28T00:58:23.000Z*
> Jiangxi Fushine Pharmaceutical Co., Ltd. released its first quarter report for 2025 and 2026. In 2025, the company's ope

### [Fushine Pharmaceuticals released its first-quarter performance, with a net profit attributable to the parent company of 61.1955 million yuan, an increase of 2633.39%](https://longbridge.com/en/news/284214361.md)
*2026-04-27T12:22:23.000Z*
> Fushine Pharmaceuticals released its Q1 2026 performance, with operating revenue of 358 million yuan, a year-on-year inc

### [](https://longbridge.com/en/news/284158551.md)
*2026-04-27T05:54:07.000Z*
> A-share pharmaceutical stocks showed volatile strength; Guangji Pharma hit the limit-up in the afternoon, while Fushine,

### [Lithium battery material stocks rise again, Hi-Tech Spring surges over 14%, reaching a historical high](https://longbridge.com/en/news/282641838.md)
*2026-04-14T06:47:28.000Z*
> On April 14th, lithium battery material stocks surged again, with Hi-Tech Spring rising over 14%, reaching a historical